Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherCLINICAL INVESTIGATIONS

Use of 201Tl SPECT for Evaluation of Biologic Behavior in Pituitary Adenomas

Takahiro Nakano, Kenichiroh Asano, Masahiko Tanaka, Toshio Takahashi, Hiroyuki Miura and Shigeharu Suzuki
Journal of Nuclear Medicine April 2001, 42 (4) 575-578;
Takahiro Nakano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenichiroh Asano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiko Tanaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshio Takahashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Miura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeharu Suzuki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Although pituitary adenomas are regarded as benign tumors, some of them behave aggressively with malignant behavior of invasion and metastasis. Prediction of such biologic behavior in a tumor is important for therapeutic planning. The purpose of this study was to assess the usefulness of 201Tl chloride SPECT (201Tl SPECT) for evaluation of biologic behavior in pituitary adenomas. Methods: 201Tl SPECT was performed on 22 patients with pituitary adenomas. 201Tl uptake indices were calculated, and the results were compared between invasive pituitary adenomas and noninvasive pituitary adenomas. Correlation of the 201Tl uptake index and the MIB1 monoclonal antibody labeling index (MIB1 labeling index) of the tumors was also estimated. Results: In comparison with noninvasive pituitary adenomas, invasive pituitary adenomas exhibited significantly higher 201Tl uptake indices on both the early and the delayed images (P = 0.0010 and 0.0019, respectively). A significant correlation was found between the 201Tl uptake index on the delayed image and the MIB1 labeling index (P = 0.0107). Conclusion: 201Tl SPECT can be useful for detecting biologic aggressiveness in pituitary adenomas.

  • pituitary adenoma
  • 201Tl SPECT
  • invasion
  • MIB1 monoclonal antibody

Although pituitary adenomas are generally regarded as benign tumors, some of them behave aggressively and manifest malignant behavior such as invasion or metastasis. Prediction of biologic behavior is important for therapeutic planning of the tumor. 201Tl chloride SPECT (201Tl SPECT) has been reported to be useful for detecting tumor viability in malignant tumors (1–7). However, to our knowledge, there have been no reports of 201Tl SPECT of pituitary adenomas. In this study, 201Tl SPECT was performed on 22 patients with pituitary adenomas and 201Tl uptake indices were calculated to determine whether it is possible to predict the biologic behavior of pituitary adenomas. We also investigated the correlation between the 201Tl index and the presence of cavernous sinus invasion by tumor and examined the MIB1 monoclonal antibody labeling index (MIB1 labeling index) as a marker of proliferative activity in the tumor (8–11).

MATERIALS AND METHODS

We studied 22 of 28 patients with pituitary adenomas who were surgically treated in our hospital between January 1997 and June 1999. 201Tl SPECT was performed preoperatively on all 22 patients (11 men, 11 women; age range, 18–65 y; mean age, 45 y). 201Tl SPECT was not performed on the other 6 patients, who were excluded from the study. All patients had early SPECT imaging 15 min after intravenous injection of 148 MBq 201Tl and delayed SPECT imaging 4 h after injection. All images were obtained with a continuous rotation of 4°/60 s, with a total of 120° per detector by means of a three-detector system with fanbeam collimators (Multispect 3; Siemens, Erlangen, Germany). We used 15% and 20% symmetric windows at 166 and 70 keV, respectively. A 128 × 128 matrix with a Butterworth filter was used for correction, and images were reconstructed on the transverse plane with a ramp filter. A transverse line was made that passed over the tumor on the axial image, and counts on the line were plotted. The 201Tl uptake index was then obtained by dividing the maximum count on the curve by the mean value of the nontumor area (Fig. 1).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Calculation of 201Tl uptake index. Transverse line was made that passed over tumor, and counts on line were plotted as curve. Maximum count (Cmax) of tumor part was divided by mean count of nontumor area (B1 and B2).

Cavernous sinus invasion by tumor was defined on the basis of MRI findings. Those tumors with a grade higher than 2 by the classification of Knosp et al. (12) were defined as invasive.

Tumor tissues were fixed in neutral buffered formalin and embedded in paraffin. Four-micrometer-thick sections were mounted onto glass slides and dried. After deparaffinization and rehydration, endogenous peroxidase activity was blocked. Slide-mounted sections were incubated in 0.01 mmol/L sodium citrate buffer (pH 6.0) and then microwaved for 20 min at 500 W. Sections were incubated overnight at 4°C in MIB1 (1:100 dilution; DAKO, Santa Barbara, CA). Sections were then incubated with biotin-conjugated secondary antibody, followed by peroxidase-conjugated streptavidin. Antigen–antibody complexes were detected with 3,3′-diaminobenzidine/H2O2. Slides were counterstained with hematoxylin, dehydrated, cleared, and mounted. In each case, >1,000 tumor cells were counted by light microscopy, and the MIB1 labeling index was expressed as a percentage.

All statistical analyses were performed with StatView, version 5.0, computer software (SAS Institute, Inc., Cary, NC). Differences in the 201Tl uptake index between the invasive tumor group and the noninvasive tumor group were evaluated by the Mann–Whitney U test.

RESULTS

Among the 22 cases of pituitary adenoma, 12 were invasive tumors and 10 were noninvasive tumors. Significant differences in the 201Tl uptake indices were found between the invasive tumor group and the noninvasive tumor group, including both the early images (Tle index) (mean ± SE, 11.40 ± 2.49 and 4.26 ± 0.41, respectively) and the delayed images (Tld index) (6.69 ± 0.71 and 3.76 ± 0.37, respectively) (Fig. 2). Threshold values were defined as 5.0 on the Tle index and 4.5 on the Tld index. Among the12 invasive tumors, 11 were >5.0 on the Tle index and 10 were >4.5 on the Tld index (sensitivity, 92% and 83%, respectively). Conversely, among the 10 noninvasive tumors, only 3 were >5.0 on the Tle index and 1 was >4.5 on the Tld index (specificity, 70% and 90%, respectively).

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

(A) Tle index was significantly greater in invasive tumor group (mean ± SE, 11.40 ± 2.49) than in noninvasive tumor group (4.26 ± 0.41) (P = 0.0010). (B) Tld index was also significantly greater in invasive tumor group (mean ± SE, 6.69 ± 0.71) than in noninvasive tumor group (3.76 ± 0.37) (P = 0.0019).

Three prolactinomas and five growth hormone–producing adenomas were included in this study. However, no correlation was found between the 201Tl index and the functional type of pituitary adenomas. No significant difference was found between the invasive tumor group and the noninvasive tumor group on the MIB1 labeling index (Table 1).

View this table:
  • View inline
  • View popup
TABLE 1

Tl Uptake Indices and MIB1 Labeling Indices in Pituitary Adenomas

The Tld index correlated significantly with the MIB1 labeling index (P = 0.0107) (Fig. 3). This finding means that the delayed image indicates proliferative activity of the tumors. A representative case is presented in Figure 4.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Tld index correlated significantly with MIB1 labeling index (P = 0.0107). Pearson’s r = 0.527.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Patient 21. (A) MR coronal T1-weighted image shows macroadenoma that extended bilateral cavernous sinuses. (B) 201Tl SPECT early image shows marked concentration of 201Tl in tumor. (C) On 201Tl SPECT delayed image, 201Tl was retained in tumor. (D) Light-microscopic section (×400). MIB1 immunostaining shows relatively high percentage of MIB1-positive cells (arrows).

DISCUSSION

Despite being regarded as benign tumors, pituitary adenomas frequently invade surrounding structures or rapidly regrow after the first operation. In therapeutic planning it is very important to predict such aggressive behavior, especially in cases of nonsymptomatic tumor found incidentally. In this study, we investigated whether the invasiveness and proliferative activity of pituitary adenomas can be predicted with 201Tl SPECT. Significant differences were found between the invasive tumor group and the noninvasive tumor group in the Tle index and the Tld index. Moreover, the MIB1 labeling index, which is a marker of tumor proliferative activity, correlated significantly with the Tld index.

Early 201Tl concentration in tumors is related to tumor vascularity and destruction of the blood–brain barrier (2). However, histologically, pituitary tissue does not have a blood–brain barrier, so even normal pituitary tissue exhibits twice the counts on 201Tl SPECT compared with surrounding normal brain structures. Therefore, in pituitary adenomas, early 201Tl concentration in the tumors is related primarily to tumor vascularity. When 201Tl is not taken into cells, it is washed out by blood flow. But when 201Tl is taken into tumor cells by active transport with Na+,K+ adenosine triphosphatase (ATPase), it is retained in the tumor cells. Thus, retention of 201Tl by the tumor is related to the activity of Na+,K+-ATPase in tumor cells (6). Therefore, the Tld index on the delayed image indicates viability of the tumor. In this study, tumor invasion was related to both the early image and the delayed image, but the MIB1 labeling index was related only to the delayed image. The explanation for these findings is that tumor invasion is related to both tumor vascularity and the proliferative activity of tumor cells (11,13), but the MIB1 labeling index is related only to the proliferative activity of tumor cells (8,10). Consequently, we can detect two different characteristics of tumors by studying the early and the delayed images of 201Tl SPECT.

Knowing the biologic characteristics of a tumor preoperatively can be significantly beneficial for therapeutic decision making; hence, many studies on the biologic behavior of pituitary adenomas have been reported (1,2,8,10,14–16). However, because most of these studies used tumor tissue specimens such as MIB1 indices, they could not be used before surgery as an index for deciding whether tumors should be removed surgically.

Although 201Tl SPECT has been reported to be useful for detecting tumor viability or tumor recurrence in malignant glioma (1,3–5,17), to our knowledge, no such study has been reported concerning pituitary adenoma. 201Tl SPECT has not been used to evaluate pituitary adenomas because 201Tl is taken up only by viable tumor cells; therefore, it has not been regarded as a useful study for benign tumors. However, in this study we performed 201Tl SPECT on patients with pituitary adenoma, calculated 201Tl uptake indices, and found that it is possible to predict the biologic behavior of these tumors. Therefore, 201Tl SPECT may be helpful to guide therapy and surgical decision making, especially for patients in whom pituitary adenoma is found incidentally.

CONCLUSION

201Tl SPECT makes prediction of the biologic behavior of pituitary adenomas potentially possible. Its clinical use may be helpful to guide therapeutic planning, especially in the case of incidentally discovered pituitary adenomas.

Footnotes

  • Received Apr. 20, 2000; revision accepted Nov. 10, 2000.

    For correspondence or reprints contact: Takahiro Nakano, MD, Department of Neurosurgery, Hirosaki University School of Medicine, Zaifucho 5, Hirosaki, 036-8562, Japan.

REFERENCES

  1. ↵
    Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989;71:342–346.
    OpenUrlPubMed
  2. ↵
    Igase K, Oka Y, Ohta S, Murakami Y, Kumon Y, Sasaki S. Usefulness of thallium-201 single photon emission computed tomography to quantify the malignancy grade of brain tumors. Neurol Med Chir (Tokyo) 1996;36:434–439.
    OpenUrlPubMed
  3. ↵
    Ishibashi M, Taguchi A, Sugita Y, et al. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 1995;36:2201–2207.
    OpenUrlAbstract/FREE Full Text
  4. Kahn D, Follett KA, Bushnell DL, et al. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. AJR 1994;163:1459–1466.
    OpenUrlCrossRefPubMed
  5. ↵
    Kosuda S, Fujii H, Aoki S, et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 1993;7:257–263.
    OpenUrlPubMed
  6. ↵
    Lorberboym M, Baram J, Feibel M, Hercbergs A, Lieberman L. A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden. Int J Radiat Oncol Biol Phys 1995;32:249–254.
    OpenUrlPubMed
  7. ↵
    Rubinstein R, Karger H, Pietrzyk U, Siegal T, Gomori JM, Chisin R. Use of 201thallium brain SPECT, image registration, and semi-quantitative analysis in the follow-up of brain tumors. Eur J Radiol 1996;21:188–195.
    OpenUrlPubMed
  8. ↵
    Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357–363.
    OpenUrlCrossRefPubMed
  9. Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano T, Hirohata T. Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas. Acta Neurochir (Wien) 1995;136:37–43.
    OpenUrlPubMed
  10. ↵
    Mizoue T, Kawamoto H, Arita K, Kurisu K, Tominaga A, Uozumi T. MIB1 immunopositivity is associated with rapid regrowth of pituitary adenomas. Acta Neurochir (Wien) 1997;139:426–432.
    OpenUrlCrossRefPubMed
  11. ↵
    Thaper K, Kovacs K, Scheithauer BW, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 1996;38:99–107.
    OpenUrlCrossRefPubMed
  12. ↵
    Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993;3:610–618.
    OpenUrl
  13. ↵
    Knosp E, Kitz K, Perneczky A. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 1989;25:927–930.
    OpenUrlCrossRefPubMed
  14. ↵
    Asano K, Kubo O, Tajika Y, Huang MC, Takakura K. The relationship between cell proliferation activity and secretory activity in pituitary adenoma: review of 63 cases [in Japanese]. No To Shinkei 1996;48:543–549.
    OpenUrlPubMed
  15. Hsu DW, Hakim F, Biller BMK, et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 1993;78:753–761.
    OpenUrlPubMed
  16. ↵
    Scheithauer BW, Kovacs KT, Laws ER, Randall RV. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 1986;65:733–744.
    OpenUrlPubMed
  17. ↵
    Alexander E III, Loeffler JS, Schwartz RB, et al. Thallium-201 technetium-99m HMPAO single-photon emission computed tomography (SPECT) imaging for guiding stereotactic craniotomies in heavily irradiated malignant glioma patients. Acta Neurochir (Wien) 1993;122:215–217.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 4
April 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Use of 201Tl SPECT for Evaluation of Biologic Behavior in Pituitary Adenomas
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Use of 201Tl SPECT for Evaluation of Biologic Behavior in Pituitary Adenomas
Takahiro Nakano, Kenichiroh Asano, Masahiko Tanaka, Toshio Takahashi, Hiroyuki Miura, Shigeharu Suzuki
Journal of Nuclear Medicine Apr 2001, 42 (4) 575-578;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Use of 201Tl SPECT for Evaluation of Biologic Behavior in Pituitary Adenomas
Takahiro Nakano, Kenichiroh Asano, Masahiko Tanaka, Toshio Takahashi, Hiroyuki Miura, Shigeharu Suzuki
Journal of Nuclear Medicine Apr 2001, 42 (4) 575-578;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire